Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens [provided by RefSeq, Jul 2008].. Zusätzlich bieten wir Ihnen Arylacetamide Deacetylase (Esterase) Antikörper (48) und Arylacetamide Deacetylase (Esterase) Proteine (11) und viele weitere Produktgruppen zu diesem Protein an.
Data suggest that metabolism (and possibly pharmacokinetics) of hypnotic nitrazepam involves liver enzymes AOX1 (aldehyde oxidase 1 (zeige AOX1 ELISA Kits)), NAT2 (N-acetyltransferase 2 (zeige NAT2 ELISA Kits)), AADAC (arylacetamide deacetylase), and CYP3A4 (cytochrome P450 3A4 (zeige CYP3A4 ELISA Kits)).
Data suggest that AADAC in hepatocyte microsomes hydrolyzes ketoconazole, a synthetic imidazole antifungal agent, to N-deacetyl ketoconazole and thus triggers hepatocellular toxicity.
AADAC deletion is a candidate susceptibility factor for Gilles de la Tourette Syndrome
Translational N-glycosylation of AADAC plays a crucial role in regulating AADAC enzyme activity.
Lipolysis of cellular TG and VLDL production were impaired in HCV infected cells during the early peak of viral infection. This was partially explained by an apparent deficiency of a putative TG lipase (zeige LIPG ELISA Kits), arylacetamide deacetylase (AADAC).
An AADAC*3 allele yields decreased enzyme activity in liver microsomes.
human AADAC was the enzyme responsible for the deacetylation of rifamycins and would affect the induction rate of drug-metabolizing enzymes by rifamycins and their induced hepatotoxicity.
two intrinsic endoplasmic reticulum (ER) proteins, 11beta-hydroxysteroid dehydrogenase, isozyme 1 (11beta-HSD (zeige CHST3 ELISA Kits)) and the 50-kDa esterase (zeige ESD ELISA Kits) (E3), sharing some amino acid sequence motifs in their N-terminal transmembrane (TM) domains.
Expression of AADA cDNA in McArdle-RH7777 cells significantly reduced intracellular triacylglycerol levels and apolipoprotein B (zeige APOB ELISA Kits) secretion and increased fatty acid oxidation.
Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens
arylacetamide deacetylase (esterase)
, arylacetamide deacetylase-like
, Arylacetamide deacetylase
, arylacetamide deacetylase
, arylacetamide deacetylase-like 2